VeriMomHamilelikte retinoyl tripeptide-1 kullanmaktan kaçınmalı mıyım? | VeriMom
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive hazard was found. No human or animal reproductive/teratogenic data demonstrating hazard were identified in PubMed/CosIng/ECHA registration summaries; therefore default hazard/mechanism = 0. Low but potentially measurable dermal absorption is plausible for a small cosmetic ingredient with a retinoyl moiety, so exposure scored as 1 (PubChem/CosIng product listings indicate typical topical cosmetic use). Sources: ECHA Annex VI (no harmonised classification), PubChem, CosIng, PubMed (no reproductive studies found).
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- retinoyl tripeptide-1 hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive hazard was found. No human or animal reproductive/teratogenic data demonstrating hazard were identified in PubMed/CosIng/ECHA registration summaries; therefore default hazard/mechanism = 0. Low but potentially measurable dermal absorption is plausible for a small cosmetic ingredient with a retinoyl moiety, so exposure scored as 1 (PubChem/CosIng product listings indicate typical topical cosmetic use). Sources: ECHA Annex VI (no harmonised classification), PubChem, CosIng, PubMed (no reproductive studies found).
- retinoyl tripeptide-1 emzirirken güvenli mi?
- No specific data on transfer to breast milk or lactation toxicity found in authoritative sources (no SCCS/CIR concerns; no harmonised CLP flags). By default hazard and mechanism are 0. Low but measurable maternal dermal exposure possible; therefore exposure = 1. Sources: SCCS/CIR absence, PubMed (no studies), CosIng, PubChem.
- retinoyl tripeptide-1 bebek cildi için güvenli mi?
- No infant-specific reproductive or toxicity data were identified. Hazard and mechanism remain 0. Because infant skin has higher absorption per kg and immature barrier, increase exposure by +1 relative to adult (adult e=1 → baby e=2). No authoritative body (CIR/SCCS/ECHA Annex VI) has issued infant-specific prohibitions for this ingredient. Sources: CosIng, PubChem, PubMed (no infant studies), ECHA (no harmonised classification).
- VeriMom retinoyl tripeptide-1 nasıl puanlıyor?
- VeriMom retinoyl tripeptide-1'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 13/100 (yüksek risk) olarak puanlar.
- Hamilelikte retinoyl tripeptide-1 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.